Assessing BAY86-9766 Plus Sorafenib for the Treatment of Liver Cancer.

Clinical trial NCT01204177 · COMPLETED

Trial details

NCT number: NCT01204177
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2010-12-01
Primary completion: 2011-08-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.